News & Perspective

Dec 22, 2008

Dec 22, 2008

FDA approves shortened anthrax-vaccine course

(CIDRAP News) – The US Food and Drug Administration (FDA) recently approved a new version of BioThrax—the nation's only licensed anthrax vaccine—that requires fewer doses and changes the injection route.

Oct 23, 2008

Oct 23, 2008

ACIP opens door to anthrax shots for first responders

(CIDRAP News) – The federal Advisory Committee on Immunization Practices (ACIP) has opened the door to voluntary anthrax vaccination for first responders, revising an 8-year-old recommendation against that step.

Oct 06, 2008

Oct 06, 2008

Trial offers hope for shortening anthrax-shot series

(CIDRAP News) – An interim report from a major study of the US's only licensed anthrax vaccine suggests it may be possible to reduce local side effects without sacrificing effectiveness by changing the injection route and using fewer doses.

Sep 11, 2008

Sep 11, 2008

Lab lapses sparked anthrax false alarm in Idaho

(CIDRAP News) – Cross-contamination of clinical specimens in two Idaho hospital laboratories that were conducting proficiency tests triggered brief concern about a potential anthrax attack in 2006, underscoring the value of proper lab practices, according to a report from the Centers for Disease Control and Prevention (CDC).

Aug 26, 2008

Aug 26, 2008

Anthrax probe prompts concerns about military labs

(CIDRAP News) –US Navy and Air Force officials recently reported a suspension of work in their biodefense laboratories to allow a thorough review of safety procedures, following the Army's announcement in early August that it would review security measures at the lab that housed the work of the late Bruce E. Ivins, whom federal officials believe played a role in the 2001 anthrax attacks.

Jun 03, 2008

Jun 03, 2008

HHS announces preparedness grants for public health, hospitals

(CIDRAP News) – The US Department of Health and Human Services (HHS) today announced that it is allocating states and major metropolitan areas $1.1 billion to strengthen public health preparedness and help healthcare facilities respond to emergency events such as an influenza pandemic or terrorist attack.

May 20, 2008

May 20, 2008

FDA approves levofloxacin for anthrax in children

(CIDRAP News) – The US Food and Drug Administration (FDA) recently offered another antibiotic option for combating inhalational anthrax in children by approving the quinolone drug levofloxacin (Levaquin).

In a letter dated May 5, the FDA endorsed the use of levofloxacin, made by Ortho-McNeil, in children 6 months of age and older. The agency had approved use of the drug for postexposure treatment of anthrax in adults in 2004.

Mar 07, 2008

Mar 07, 2008

CDC retires one old smallpox vaccine, keeps another

(CIDRAP News) – Federal health officials recently announced plans to get rid of their last remaining stocks of the decades-old smallpox vaccine Dryvax, as a newer vaccine takes its place in the national stockpile of emergency medical supplies.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»